Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Foxp3 plays a key role in CD4 + CD25 + T reg cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4 + T cell activation by plate‐bound anti‐CD3 Ab as well as the relationship between its expression and regulatory function at the single‐cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4 + CD25 – cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4 + CD25 ++ T reg cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T reg cells. See accompanying commentary http://dx.doi.org/10.1002/eji.200636929
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, stimulation with immobilized CD3 mAb is known to increase FoxP3 expression that is strongly associated with hypo-responsiveness by activated CD4+ T-cells and is not directly correlated with suppressive capability 37 . It is, therefore, likely that this is also the case with TGN1412 in the solid phase assay since both TGN1412 and muromonab-CD3 stimulate a similar cytokine response.”
From Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release (2013) · cites this paper as [37]
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [386]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Cited by
Items 201–300 of 1,000
Kidney Fibrosis: Origins and Interventions
Vanhove, T., Goldschmeding, R., & Kuypers, D. R. J. (2016) · Transplantation · doi:10.1097/tp.0000000000001608 · Cited by 107
“112 Some reports have indicated that FOXP3 expression mainly mirrors the general degree of inflammation and FOXP3 expression in acute rejections carries no prognostic benefit.”
Dotan, I., Allez, M., Danese, S., Keir, M. E., Tole, S., & McBride, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21601 · Cited by 113
Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites
Chulanetra, M., & Chaicumpa, W. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.702125 · Cited by 111
Santegoets, S. J. A. M., Stam, A. G. M., Lougheed, S. M., Gall, H. E., Scholten, P. E. T., Reijm, M., Jooss, K. U., Sacks, N., Hege, K. M., Lowy, I., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1330-5 · Cited by 97
Imbalance of regulatory T cells to Th17 cells in IgA nephropathy
Lin, F. F., Jiang, G.-R., Shan, J., Zhu, C. F., Zou, J., & Wu, X. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.652158 · Cited by 91
Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
Povoleri, G. A. M., Scottà, C., Nova‐Lamperti, E., John, S., Lombardi, G., & Afzali, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00169 · Cited by 122
“, 2005c; Wan and Flavell, 2005); in humans, however, FOXP3 does not allow the unambiguous identification of Tregs (Ziegler, 2006) as it is induced during TCR stimulation in conventional CD4 T cells (Walker et al., 2003; Gavin et al., 2006; Wang et al., 2007) (in much the same manner as CD25) and there has been some de…”
BackgroundRole of orally induced regulatory T cells in immunotherapy and tolerance
Bertolini, T. B., Biswas, M., Terhorst, C., Daniell, H., Herzog, R. W., & Piñeros, A. R. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104251 · Cited by 98
“FoxP3− cells may also transiently express FoxP3 during activation [57].”
BackgroundRevenko, A. S., Carnevalli, L. S., Sinclair, C., Johnson, B., Peter, A., Taylor, M. A., Hettrick, L. A., Chapman, M., Klein, S., Solanki, A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003892 · Cited by 96
The CD4 T cell response to respiratory syncytial virus infection
Christiaansen, A. F., Knudson, C. J., Weiss, K. A., & Varga, S. M. (2014) · Immunologic Research · doi:10.1007/s12026-014-8540-1 · Cited by 100
“Activated conventional human CD4 T cells can transiently express Foxp3, requiring the use of additional markers to identify Tregs [43].”
BackgroundMarcq, E., Siozopoulou, V., De Waele, J., van Audenaerde, J., Zwaenepoel, K., Santermans, E., Hens, N., Pauwels, P., van Meerbeeck, J. P., & Smits, E. L. J. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1261241 · Cited by 88
“vated non-suppressive T cell populations, so it is not a 100% specific Treg marker.(51) More CD4CFoxP3C cells in the stroma were also associated with more CD68C macrophages in the”
BackgroundLi, B., & Greene, M. I. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02774.x · Cited by 88
Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis
Aerts, N. E., Dombrecht, E. J., Ebo, D. G., Bridts, C. H., Stevens, W. J., & Clerck, L. S. D. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.04.008 · Cited by 93
Dimova, T., Nagaeva, O., Stenqvist, A., Hedlund, M., Kjellberg, L., Strand, M., Dehlin, E., & Mincheva‐Nilsson, L. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01046.x · Cited by 87
Huertas, A., Phan, C., Bordenave, J., Tu, L., Thuillet, R., Hiress, M. L., Avouac, J., Tamura, Y., Allanore, Y., Jovan, R., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.01.004 · Cited by 93
The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients
Tahmasebi, S., Qasim, M. T., Krivenkova, M. V., Zekiy, A. O., Thangavelu, L. P., Surendar, A., Izadi, M., Jadidi‐Niaragh, F., Ghaebi, M., Aslani, S., et al. (2021) · Cell Biology International · doi:10.1002/cbin.11589 · Cited by 95
“FoxP3+ expression is at a low level in activated T CD4+ cells and T CD8+ cells and at a high level in CD4+CD25+ T cells (Wang et al., 2007).”
BackgroundKindlund, B., Sjöling, Å., Yakkala, C., Adamsson, J., Janzon, A., Hansson, L., Hermansson, M., Janson, P., Winqvist, O., & Lundin, S. B. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0591-z · Cited by 99
“Several publications have shown that CpG demethylation of regulatory elements in the FOXP3 locus support stable expression of FOXP3 and a suppressive phenotype [33, 34].”
BackgroundThe progress and prospect of regulatory T cells in autoimmune diseases
Zhang, X., Olsen, N. J., & Zheng, S. G. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102461 · Cited by 96
Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis
Allenbach, Y., Chaara, W., Rosenzwajg, M., Six, A., Prevel, N., Mingozzi, F., Wanschitz, J., Musset, L., Charuel, J. L., Eymard, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088788 · Cited by 84
“Although Foxp3 can be expressed by activated T cells that do not display suppressive functions [15], we confirmed, based on CD45RA expression [16], that FoxP3 cells correspond to true Tregs and that the observed Tregs decrease concerned mainly aTregs.”
BackgroundRegulatory T cells in solid organ transplantation
Atif, M., Conti, F., Gorochov, G., Oo, Y. H., & Miyara, M. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1099 · Cited by 86
Czaja, A. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12825 · Cited by 84
Pan, X., Yuan, X., Zheng, Y., Wang, W., Shan, J., Lin, F. F., Jiang, G., Yang, Y. H., Wang, D., Xu, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034662 · Cited by 83
“also induced in activated T cells [12,13,14].”
Graham, J. G., Zhang, X., Goodman, A., Pothoven, K., Houlihan, J., Wang, S., Gower, R. M., Luo, X., & Shea, L. D. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0643 · Cited by 82
“transiently express Foxp3 on activation, we observe minimal Foxp3 expression in the - Treg condition and robust Foxp3 expression in the + Treg condition, implying a regulatory phenotype of the Foxp3 + cells present in the protected graft.(29) The Tregs observed in the graft at day 7 were those initially transplanted (…”
Regulatory T‐cell development in the tumor microenvironment
Itahashi, K., Irie, T., & Nishikawa, H. (2022) · European Journal of Immunology · doi:10.1002/eji.202149358 · Cited by 93
MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
Vanhaver, C., van der Bruggen, P., & Bruger, A. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132872 · Cited by 84
Tumor-specific regulatory T cells in cancer patients
Piersma, S. J., Welters, M. J. P., & van der Burg, S. H. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.02.005 · Cited by 92
Ménétrier‐Caux, C., Curiel, T. J., Faget, J., Manuel, M., Caux, C., & Zou, W. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0208-y · Cited by 93
“[8–10].”
Saini, C., Siddiqui, A., Ramesh, V., & Nath, I. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004592 · Cited by 81
“Alternatively, the results may indicate the transient nature of FOXP3 expression [25,40].”
BackgroundTargeting latency-associated peptide promotes antitumor immunity
Gabriely, G., da Cunha, A. P., Rezende, R. M., Kenyon, B., Madi, A., Vandeventer, T., Skillin, N., Rubino, S., Garo, L., Mazzola, M. A., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aaj1738 · Cited by 78
“Foxp3 can also be transiently expressed in activated effector T cells in humans (30), and the accumulation of a Foxp3-lo population, represented by non-Tregs, correlates with better survival of CRC patients than Foxp3-hi cells (31).”
BackgroundRegulatory T cells in the prevention of mucosal inflammatory diseases: Patrolling the border
Lan, R. Y., Mackay, I. R., & Gershwin, M. E. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.07.021 · Cited by 92
“However in humans, unlike mice, FoxP3 expression can be induced in naïve, CD4+CD25− T cells upon conventional stimulation, with an expression rate up to 90% after seven days of stimulation [23,24]; activated T cells that sustain FoxP3 expression after a one-week rest following stimulation acquired regulatory function…”
BackgroundNowak, A., Lock, D., Bacher, P., Hohnstein, T., Vogt, K., Gottfreund, J., Giehr, P., Polansky, J. K., Sawitzki, B., Kaiser, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00199 · Cited by 78
Regulation of the foxp3 Gene by the Th1 Cytokines: The Role of IL-27-Induced STAT1
Ouaked, N., Mantel, P.-Y., Bassin, C., Burgler, S., Siegmund, K., Akdis, C. A., & Schmidt-Weber, C. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.1041 · Cited by 78
Molecular orchestration of differentiation and function of regulatory T cells
Lu, L.-F., & Rudensky, A. (2009) · Genes & Development · doi:10.1101/gad.1791009 · Cited by 78
“Furthermore, Foxp3 up-regulation upon human T-cell activation is transient and results in levels of Foxp3 markedly lower than those in human Treg cells (Gavin et al. 2006; Wang et al. 2007).”
BackgroundA novel function for FOXP3 in humans: intrinsic regulation of conventional T cells
McMurchy, A. N., Gillies, J., Gizzi, M. C., Riba, M., Garcia-Manteiga, J. M., Cittaro, D., Lazarevic, D., Di Nunzio, S., Piras, I. S., Bulfone, A., et al. (2013) · Blood · doi:10.1182/blood-2012-05-431023 · Cited by 77
Nagar, M., Vernitsky, H., Cohen, Y., Dominissini, D., Berkun, Y., Rechavi, G., Amariglio, N., & Goldstein, I. (2008) · International Immunology · doi:10.1093/intimm/dxn062 · Cited by 87
Suchard, M. S., Mayne, E. S., Green, V. A., Shalekoff, S., Donninger, S. L., Stevens, W. S., Gray, C. M., & Tiemessen, C. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011762 · Cited by 84
“There is also however conflicting evidence suggesting that FOXP3 expression in humans may not be confined to cells with regulatory function [44,56,57,58,59].”
BackgroundNigam, P., Velu, V., Kannanganat, S., Chennareddi, L. S., Kwa, S., Siddiqui, M., & Amara, R. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902955 · Cited by 83
Basso, P. J., Fonseca, M. T., Bonfá, G., Alves, V. B. F., Sales‐Campos, H., Nardini, V., & Cardoso, C. R. D. B. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143932 · Cited by 92
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T‐regulatory cells
Ai, W. Z., Hou, J., Zeiser, R., Czerwinski, D. K., Negrin, R. S., & Levy, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23881 · Cited by 76
“This discordance has been reported for human CD41 T cells activated by TCR stimulation with antiCD3 and costimulation with CD28.”
BackgroundInfluentialSuzuki, M., Jagger, A. L., Konya, C., Shimojima, Y., Pryshchep, S., Goronzy, J. J., & Weyand, C. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200122 · Cited by 74
“which transiently express FOXP3 after TCR-mediated activation (5), this transcription factor is useful in identifying and monitoring Treg populations.”
BackgroundChen, L. C., Delgado, J. C., Jensen, P. E., & Chen, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901081 · Cited by 79
Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response?
Groth, B. F. D. S., & LANDAY, A. L. (2008) · AIDS · doi:10.1097/qad.0b013e3282f466da · Cited by 83
GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients
Hjorth, M., Axelsson, S., Rydén, A., Faresjö, M., Ludvigsson, J., & Casas, R. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.10.004 · Cited by 73
Interplay of Regulatory T Cell and Th17 Cells during Infectious Diseases in Humans and Animals
Sehrawat, S., & Rouse, B. T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00341 · Cited by 79
The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
Frafjord, A., Buer, L., Hammarström, C. L., Aamodt, H., Woldbæk, P. R., Brustugun, O. T., Helland, Å., Øynebråten, I., & Corthay, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.764596 · Cited by 82
“Most human CD4 and CD8 T cells have been reported to upregulate FOXP3 upon activation (48, 57, 58).”
BackgroundLeukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis
Janssens, K., den Haute, C. V., Baekelandt, V., Lucas, S., van Horssen, J., Somers, V. A., Wijmeersch, B. V., Stinissen, P., Hendriks, J. J. A., Slaets, H., et al. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.11.010 · Cited by 76
Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells
Wang, C., Yi, T., Qin, L., Maldonado, R. A., von Andrian, U. H., Kulkarni, S., Tellides, G., & Pober, J. S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66204 · Cited by 73
“In humans, FoxP3 is not an exclusive marker of Tregs, as it is also transiently expressed on activated conventional CD4 + T cells (48, 49).”
Jin, L., Hasegawa, H., Matsumoto, T., & Yasukawa, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001437 · Cited by 74
Mechanisms of T cell organotropism
Fu, H., Ward, E. J., & Marelli-Berg, F. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2211-4 · Cited by 71
“It must also be considered that high levels of CD25 and FoxP3 are transiently expressed by recently activated human T cells, which do not display suppressor functions [262, 263].”
BackgroundRegulatory T Cells As Potential Targets for HIV Cure Research
Kleinman, A. J., Sivanandham, R., Pandrea, I., Chougnet, C. A., & Apetrei, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00734 · Cited by 79
“FoxP3 expression can also be transiently induced following in vitro stimulation of nonsuppressive CD25neg CD4+ T cells, which indicates that expression of FoxP3 alone is not responsible for the regulatory activity of T cells (52).”
BackgroundPinheiro, D., Singh, Y., Grant, C. R., Appleton, R. C., Sacchini, F., Walker, K. R. L., Chadbourne, A. H., Palmer, C. A., Armitage‐Chan, E. A., Thompson, I., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03346.x · Cited by 72
Zhang, X., Peng, J., Sun, J., Liu, J., Guo, C., Wang, Z., Yu, Y., Shi, Y., Qin, P., Li, S.-G., et al. (2008) · Blood · doi:10.1182/blood-2008-03-148288 · Cited by 80
Beal, A. M., Ramos-Hernández, N., Riling, C. R., Nowelsky, E. A., & Oliver, P. M. (2012) · Nature Immunology · doi:10.1038/ni.2154 · Cited by 72
“However, expression of Foxp3 is not sufficient to define a regulatory T cell, as activated T cells can transiently upregulate Foxp3 45 along with transcription factors that dictate other T cell fates.”
IL‐15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3
Imamichi, H., Sereti, I., & Lane, H. C. (2008) · European Journal of Immunology · doi:10.1002/eji.200737607 · Cited by 82
Barzaghi, F., Passerini, L., Gambineri, E., Mannurita, S. C., Cornu, T. I., Kang, E., Choe, Y. H., Cancrini, C., Corrente, S., Ciccocioppo, R., et al. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.12.009 · Cited by 76
“Indeed, peripheral Treg cell detection and quantification in humans has been so far limited by the fact that the main markers for their identification, CD25 and FOXP3, are also expressed by activated Teff cells [2,22,23], which can be increased in inflammatory conditions [22,24], typically occurring in autoimmune dise…”
BackgroundBonelli, M. M., Smolen, J. S., & Scheinecker, C. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117135 · Cited by 74
Law, J. P., Hirschkorn, D. F., Owen, R. E., Biswas, H. H., Norris, P. J., & Lanteri, M. C. (2009) · Cytometry Part A · doi:10.1002/cyto.a.20815 · Cited by 71
Rodríguez-Perea, A. L., Montoya, C. J., Olek, S., Chougnet, C. A., & Velilla, P. A. (2015) · Journal of Immunology Research · doi:10.1155/2015/762506 · Cited by 71
“Because activated human conventional CD4 T cells can also express CD25 and FOXP3 [4, 5], this epigenetic feature is considered as a more reliable marker to distinguish between activated T cells and real Treg [3].”
BackgroundFc Receptor-Like 3 Protein Expressed on IL-2 Nonresponsive Subset of Human Regulatory T Cells
Nagata, S., Ise, T., & Pastan, I. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802230 · Cited by 74
Alternative Splicing of FOXP3—Virtue and Vice
Mailer, R. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00530 · Cited by 76
Tănăsescu, R., Tench, C. R., Constantinescu, C. S., Telford, G., Singh, S., Frakich, N., Onion, D., Auer, D. P., Gran, B., Evangelou, N., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1118 · Cited by 76
A Unique Population: Adipose-Resident Regulatory T Cells
Zeng, Q., Sun, X., Xiao, L., Xie, Z., Bettini, M., & Deng, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02075 · Cited by 70
“It is also notable that in many studies the Treg cell abundance was indicated by Foxp3 mRNA levels, which is not an ideal indicator of Treg cells because Foxp3 is expressed by a significant proportion of non-Treg cells in humans (81).”
BackgroundSchmidt, A., Marabita, F., Kiani, N. A., Groß, C. C., Johansson, H. J., Éliás, S., Rautio, S., Eriksson, M., Fernandes, S. J., Silberberg, G., et al. (2018) · BMC Biology · doi:10.1186/s12915-018-0518-3 · Cited by 74
“FOXP3 regulation is incompletely understood particularly in the human system despite accumulating evidence for differing FOXP3 regulation in mice versus human such as activation-induced low-level FOXP3 expression in human but not murine conventional T cells [4, 6, 7] and expression of different FOXP3 isoforms in human…”
BackgroundCari, L., Rosa, F. D., Nocentini, G., & Riccardi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051142 · Cited by 77
Combination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells
Long, S. A., & Buckner, J. H. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.12.012 · Cited by 72
“In humans, FOXP3 expression occurs upon activation of CD4þ T cells [17e19] and addition of IL-2 in this setting increases expression levels of FOXP3 [19].”
BackgroundKaiser, Y., Lepzien, R., Kullberg, S., Eklúnd, A., Smed‐Sörensen, A., & Grünewald, J. (2016) · European Respiratory Journal · doi:10.1183/13993003.00092-2016 · Cited by 75
Expansion of circulating Foxp3+CD25bright CD4+ T cells during specific venom immunotherapy
Pereira‐Santos, M. C., Baptista, A. P., Melo, A., Alves, R. R., Soares, R. S., Pedro, E., Pereira‐Barbosa, M., Victorino, R. M. M., & Sousa, A. E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02887.x · Cited by 69
Ubiquitin‐dependent regulation of Foxp3 and Treg function
Barbi, J. J., Pardoll, D. M., & Pan, F. (2015) · Immunological Reviews · doi:10.1111/imr.12312 · Cited by 68
Verma, N. D., Lam, A. D., Chiu, C., Tran, G. T., Hall, B. M., & Hodgkinson, S. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-88448-5 · Cited by 86
Zhang, B., Zhang, X., Tang, F., Zhu, L., & Liu, Y. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03686.x · Cited by 68
Are rats more human than mice?
Wildner, G. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.09.002 · Cited by 67
Chapter 2 How the Immune System Achieves Self–Nonself Discrimination During Adaptive Immunity
Jiang, H., & Chess, L. (2009) · Advances in immunology · doi:10.1016/s0065-2776(09)01202-4 · Cited by 88
Kanakry, C. G., Hess, A. D., Gocke, C. D., Thoburn, C. J., Kos, F. J., Meyer, C. F., Briel, J., Luznik, L., Smith, B. D., Levitsky, H. I., et al. (2010) · Blood · doi:10.1182/blood-2010-04-277939 · Cited by 74
Liovat, A.-S., Jacquelin, B., Ploquin, M. J.-Y., Barré‐Sinoussi, F., & Müller-Trutwin, M. C. (2009) · Current HIV Research · doi:10.2174/157016209787048546 · Cited by 72
“However, it has yet to be demonstrated if the FoxP3 + cells detected in AGMs correspond to Treg cells, since FoxP3 and CD25 are also upregulated upon activation [117].”
BackgroundXiong, Z., Yan, Y., Song, J., Fang, P., Yin, Y., Yu, Y., Cowan, A., Wang, H., & Yang, X. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.041 · Cited by 67
Ladányi, A., Mohos, A., Somlai, B., Liszkay, G., Gilde, K., Fejôs, Z., Gaudi, I., & Tı́már, J. (2010) · Pathology & Oncology Research · doi:10.1007/s12253-010-9254-x · Cited by 67
“lymphocytes as well [26–29], in previous immunohistochemical studies on melanoma all FOXP3 cells expressed CD3 and almost all of them CD4 and CD25 as well [18, 19], suggesting that the vast majority of tumor-infiltrating FOXP3 cells are CD4CD25 T lymphocytes.”
BackgroundLamb, C. A., Mansfield, J. C., Tew, G. W., Gibbons, D. L., Long, A. K., Irving, P. M., Diehl, L. J., Eastham-Anderson, J., Price, M., O’Boyle, G., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw189 · Cited by 75
Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells
Kumar, P., Saini, S., Khan, S. M., Lele, S. S., & Prabhakar, B. S. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.09.008 · Cited by 77
“Recent studies argue that Foxp3 expression alone is insufficient for optimal Treg function [61, 62].”
BackgroundAt the crossroads of T helper lineage commitment—Epigenetics points the way
Janson, P., Winerdal, M. E., & Winqvist, O. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.003 · Cited by 71
Li, S., Simoni, Y., Becht, É., Loh, C. Y., Li, N., Lachance, D. M., Koo, S., Lim, T. P., Tan, E., Mathew, R., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100039 · Cited by 80
Seddiki, N., Cook, L., Hsu, D. C., Phetsouphanh, C., Brown, K., Xu, Y., Kerr, S. J., Cooper, D. A., Munier, C. M. L., Pett, S., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344102 · Cited by 66
Komura, T., Sakai, Y., Harada, K., Kawaguchi, K., Takabatake, H., Kitagawa, H., Wada, T., Honda, M., Ohta, T., Nakanuma, Y., et al. (2015) · Cancer Science · doi:10.1111/cas.12663 · Cited by 68
Immunosuppressive Drugs and Tregs: A Critical Evaluation!
Serres, S. A. D., Sayegh, M. H., & Najafian, N. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03180509 · Cited by 74
Matthias, J., Heink, S., Picard, F. S. R., Zeiträg, J., Kolz, A., Chao, Y.-Y., Soll, D., de Almeida, G. P., Glasmacher, E., Jacobsen, I. D., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137786 · Cited by 74
“Furthermore, the stable maintenance of increased human FoxP3 expression in T cells over time and in changing microenvironments would stress the antiinflammatory human T cell functionality, whereas transient FoxP3 upregulation instead correlates with human T cell activation according to previous reports (31, 32).”
ResultRegulatory T cells in viral hepatitis
Billerbeck, E. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i36.4858 · Cited by 66
Helper T Cell Plasticity: Impact of Extrinsic and Intrinsic Signals on Transcriptomes and Epigenomes
Bonelli, M., Shih, H.-Y., Hirahara, K., Singelton, K., Laurence, A., Poholek, A., Hand, T., Mikami, Y., Vahedi, G., Kanno, Y., et al. (2014) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2014_371 · Cited by 65
“This is important to keep in mind insofar as FOXP3 is generally more fluid in its expression in human cells, and is broadly induced in activated T cells, and is not necessarily associated with suppressor cell functionality (Wang et al. 2007; Roncador et al. 2005).”
Whiteside, T. L., & Jackson, E. K. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00212 · Cited by 70
Mourmouras, V., Fimiani, M., Rubegni, P., Epistolato, M. C., Malagnino, V., Cardone, C., Cosci, E., Nisi, M. C. D., & Miracco, C. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08057.x · Cited by 66
Human lung tumor FOXP3+ Tregs upregulate four “Treg-locking” transcription factors
Akimova, T., Zhang, T., Negorev, D. G., Singhal, S. K., Stadanlick, J. E., Rao, A., Annunziata, M. J., Levine, M. H., Beier, U. H., Diamond, J. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.94075 · Cited by 66
“In contrast, iTregs, which can be distinguished from activated human Teffs expressing FOXP3 by documenting suppressive function (39, 40), have only a partially demethylated TSDR (17, 18, 41).”
BackgroundVolta, V., Pérez-Baos, S., de la Parra, C., Katsara, O., Ernlund, A. W., Dornbaum, S., & Schneider, R. J. (2021) · Nature Communications · doi:10.1038/s41467-021-27087-w · Cited by 64
Type 1 Regulatory T Cells and Regulatory B Cells Induced by Tolerogenic Dendritic Cells
Volchenkov, R., Karlsen, M., Jonsson, R., & Appel, S. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12039 · Cited by 65
CD4 + CD25 low GITR + cells: A novel human CD4 + T‐cell population with regulatory activity
Bianchini, R., Bistoni, O., Alunno, A., Petrillo, M. G., Ronchetti, S., Sportoletti, P., Bartoloni, E., Nocentini, G., Gerli, R., & Riccardi, C. (2011) · European Journal of Immunology · doi:10.1002/eji.201040943 · Cited by 68
Cellular immunity in Wegener's granulomatosis: Characterizing T lymphocytes
Berden, A. E., Kallenberg, C. G. M., Savage, C. O. S., Yard, B. A., Abdulahad, W. H., de Heer, E., BRUIJN, J. A., & Bajema, I. M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24576 · Cited by 69
Antigen-specific regulatory T cells in bovine paratuberculosis
de Almeida, D. E., Colvin, C. J., & Coussens, P. M. (2008) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.05.019 · Cited by 76
“…Foxp3 can also be expressed in non-suppressive human activated CD4+ CD25 T cells after in vitro stimulation, but this Foxp3 expression is transient, while it was stably expressed in activated T cells that do display suppressive function, and in natural CD4+ CD25+ Treg cells (Wang et al., 2007).”
BackgroundStrauss, L., Bergmann, C., & Whiteside, T. L. (2007) · International Journal of Cancer · doi:10.1002/ijc.23001 · Cited by 63
Zhuo, C., Li, Z., Xu, Y., Wang, Y., Li, Q., Peng, J., Zheng, H., Wu, P., Li, B., & Cai, S. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-153 · Cited by 65
Rajendran, M., Looney, S., Singh, N., Elashiry, M., Meghil, M. M., El-Awady, A. R., Tawfik, O., Susin, C., Arce, R. M., & Cutler, C. W. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900046 · Cited by 63
“CD4CD25(2) conventional T cells transiently express FOXP3 following in vitro stimulation (69); the detected IL-17A– producing FOXP3 CD4 T cells in HCs and PD patients might have differentiated mostly from MTregs (31, 70) as the percentage of MTregs was significantly higher in PD patients compared with”
ResultTumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
Schulze, A. B., Evers, G., Görlich, D., Möhr, M., Marra, A., Hillejan, L., Rehkämper, J., Schmidt, L. H., & Heitkötter, B. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-19-3414a · Cited by 108
“Of interest, FOXP3 is not exclusively expressed on Treg cells but might also be transiently found on activated CD4 CD25 Th cells (24,25) and CD8 Tc cells (26).”
BackgroundNgalamika, O., Liang, G., Zhao, M., Yu, X., Yang, Y., Yin, H., Liu, Y., Yung, S., Chan, T. M., & Lu, Q. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.938165 · Cited by 62
“Incomplete or no demethylation of the FOXP3 TSDR has been observed in activated conventional CD4+ T cells and induced Tregs (iTregs), which have both been found to express FOXP3 (Wang et al., 2007).”
BackgroundDing, H., Dai, Y., Lei, Y., Wang, Z., Liu, D., Li, R., Shen, L., Gu, N., Zheng, M., Zhu, X., et al. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0186-9 · Cited by 69
Schmiedel, Y., Mombo‐Ngoma, G., Labuda, L. A., Janse, J. J., de Gier, B., Adégnika, A. A., Issifou, S., Kremsner, P. G., Smits, H. H., & Yazdanbakhsh, M. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003995 · Cited by 62
“Moreover studies with more extensive panels of markers associated with suppressive T cell functions are necessary as FOXP3 expression has been shown to be transiently up-regulated on activated CD4 T cells [37].”
Background
Metadata
- Authors
- Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Toes, René E. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2006-12-21
- Volume
- 37
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984909066
- Cited by
- 1,011
- References
- 43
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 24 · 2023: 29 · 2022: 25 · 2021: 36 · 2020: 39 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 43 · 2015: 47 · 2014: 61 · 2013: 63 · 2012: 69
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, regulatory T cells, CD4+ T cell activation, T cell hyporesponsiveness, CD25, anti-CD3 stimulation, human T cells
- MeSH terms
- Cells, Cultured, Humans, Lymphocyte Activation, Time Factors, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Resting Phase, Cell Cycle, Cytokines, Self Tolerance, Coculture Techniques, Cell Proliferation, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.